29-May-2023 | D | Board Meeting Outcome for Considered And Approved The Standalone Financial Result For The Quarter And Financial Year Ended March 31, 2023 And Recommended Final Dividend
Recommendation of final dividend of 5% (Rs. 0.50 per equity share of Rs. 10 each face value) for the Financial Year 2022-23, subject to the approval of shareholders in the ensuing Annual General Meeting. | 15-Sep-2023 | |
28-May-2022 | D | The Board of Directors of the Company in their meeting held to-day have approved and taken on record financial results, on standalone for quarter/year ended on 31st March, 2022 audited by the Company''s Statutory Auditors, M/s Maak & Associates and reviewed by Company'' Audit Committee in their meeting also held earlier today. The Board of Directors have also recommended the final dividend of 5% (Rs. 0.50 per equity share of Rs. 10 each face value) for the financial year 2021-22, subject to the approval of the Shareholders in the ensuing Annual General Meeting.
Intimation Of Record Date For The Purpose Of Dividend For The Financial Year 2021-22.
(As Per BSE Announcement Dated on 10.09.2022)
| 22-Sep-2022 | |
16-Jul-2019 | D | With reference to above subject and in compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit the outcome of the Meeting of the Board of Director held on 15th July, 2019 at 01:00 p.m. and concluded on 02:00 p.m.
Board of Directors has recommended a dividend @ Rs. 0.50/- per Equity Shares, i.e. 5 % on Equity Shares subject to approval of members at the ensuing Annual General Meeting.
| 19-Sep-2019 | |
29-May-2018 | D | Shukra Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 29, 2018, inter alia, have recommended a dividend of Rs. 0.5/- per Equity share, i.e. @ 5% on Equity shares subject to approval of members at the ensuing Annual General Meeting. | 31-Aug-2018 | |
01-Jun-2017 | D | Shukra Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2017, inter alia, have recommended a dividend @ Rs. 0.5/ - per Equity Shares, i.e.5% on Equity Shares subject to approval of members at the ensuing Annual General Meeting. | 01-Sep-2017 | |
08-Apr-2024 | B | 3:1 Bonus Issues of Equity Shares
Trading Members of the Exchange are hereby informed that, SHUKRA PHARMACEUTICALS LIMITED has fixed Record Date for the purpose of Bonus Issue of Equity Shares of the Company. The transactions in the Equity Shares of the Company would be on an Ex-Bonus basis with effect from the under mentioned date :-
DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT
COMPANY NAME & CODE
SHUKRA PHARMACEUTICALS LIMITED
(524632)
RECORD DATE
20/04/2024
PURPOSE
Issue of 03 (Three) Bonus Equity Shares of Rs.10/- each for every 01 (One) existing Equity Share of Rs.10/- each held.
Ex-Bonus basis from Date & Sett. No.
19/04/2024 DR- 614/2024-2025
(As Per BSE Notice Dated on 09.04.2024) | 20-Apr-2024 | 3:1 |
18-Jan-2023 | R | 6:1 Rights Issue of Equity Shares
Trading Members of the Exchange are hereby informed that, Shukra Pharmaceuticals Limited has fixed Record date for the purpose of Rights Issue of Equity Shares. The transactions in the Equity Shares of the Company should be done on Ex-Rights basis with effect from the under mentioned date :-
DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT
COMPANY NAME & CODE
Shukra Pharmaceuticals Limited
(524632)
RECORD DATE
02.02.2023
PURPOSE
Issue of 6 (Six) Equity Shares of Rs.10/- each for cash at a premium of Rs.10/- on rights basis for every 01 (One) Equity Share held.*
Ex-Right basis from Date & Sett. No.
02/02/2023 DR-711/2022-2023
* Note : Issue Price of Rs.20/- payabe as - An amount of Rs. 5 per Rights Equity Share to be paid on Application and balance to be paid in three calls as determined by our Board at its sole discretion from time to time.
Trading Members of the Exchange are requested to take note of it.
(As Per BSE Notice Dated on 31.01.2023) | 02-Feb-2023 | 6:1 |
25-Apr-2024 | BC | The Company is informing the exchange about allotment of bonus shares
The Company has received approval from shareholders to issue bonus shares through postal ballot on April 03rd 2024 and the BSE | 25-Apr-2024 | |
06-Apr-2024 | BC | The Board of directors has April 20, 2024 as record date. | 20-Apr-2024 | |
08-Apr-2024 | BC | 3:1 Bonus Issues of Equity Shares
Trading Members of the Exchange are hereby informed that, SHUKRA PHARMACEUTICALS LIMITED has fixed Record Date for the purpose of Bonus Issue of Equity Shares of | 20-Apr-2024 | |
06-Apr-2024 | BC | The Board of directors has April 20, 2024 as record date. | 06-Apr-2024 | |
29-Feb-2024 | BC | Approved postal ballot notice for seeking consent of Members of the Company for the Resolutions as set out in the postal ballot Notice and other matters inci thereto.
The Company hereby submits th | 03-Apr-2024 | |
Announcement Date29-May-2023
Ex Dividend Date15-Sep-2023
Dividend(%)5
Announcement Date28-May-2022
Ex Dividend Date22-Sep-2022
Dividend(%)5
Announcement Date16-Jul-2019
Ex Dividend Date19-Sep-2019
Dividend(%)5
Announcement Date29-May-2018
Ex Dividend Date31-Aug-2018
Dividend(%)5
Announcement Date01-Jun-2017
Ex Dividend Date01-Sep-2017
Dividend(%)5
Record Date20-Apr-2024
Ex-Bonus Date19-Apr-2024
Ratio3:1
No Split has been declared by SHUKRAPHARMACEUTICALS
RightsRecord Date01 Jan'1900
Ex-Rights Date01 Jan'1900
Premium(Rs.)10
Ratio6:1
Book Closure
25-Apr-2024 | - | The Company is informing the exchange about allotment of bonus shares
The Company has received approval from shareholders to issue bonus shares through postal ballot on April 03rd 2024 and the BSE |
20-Apr-2024 | - | The Board of directors has April 20, 2024 as record date. |
20-Apr-2024 | - | 3:1 Bonus Issues of Equity Shares
Trading Members of the Exchange are hereby informed that, SHUKRA PHARMACEUTICALS LIMITED has fixed Record Date for the purpose of Bonus Issue of Equity Shares of |
06-Apr-2024 | - | The Board of directors has April 20, 2024 as record date. |
03-Apr-2024 | 01 Jan'1900 | Approved postal ballot notice for seeking consent of Members of the Company for the Resolutions as set out in the postal ballot Notice and other matters inci thereto.
The Company hereby submits th |